Lv11
20 积分 2026-09-10 加入
Long-term Effects of Repeated Botulinum Toxin Injection in Cosmetic Therapeutics
17分钟前
已完结
Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis
20天前
已完结
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
27天前
已完结
A Decade of Change: Systemic Treatment Patterns in Clinically Small HER2-Positive Node-Negative Breast Cancer in the Netherlands: A Population-Based Study
1个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
1个月前
已完结
Garsorasib (D-1553) in Combination With Pembrolizumab and Chemotherapy for First-Line Metastatic NSCLC With KRAS G12C Mutation: Results of a Phase 1b Study
1个月前
已关闭
Safety and efficacy of olomorasib + immunotherapy in first-line treatment of patients with KRAS G12C-mutant advanced NSCLC: Update from the LOXO-RAS-20001 trial
1个月前
已关闭
Fulzerasib plus cetuximab in first-line KRAS(G12C)-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial
1个月前
已完结
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRAS(G12C) mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
1个月前
已关闭
Glecirasib in KRAS(G12C)-mutated nonsmall-cell lung cancer: a phase 2b trial
1个月前
已完结